OxThera Intellectual Property AB
556744-2677InactiveDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Oversigt
- 0
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2007
- Grundlagt
Beskrivelse
OxThera AB is a privately-held biopharmaceutical company dedicated to developing novel treatment options for rare kidney diseases, primarily Primary Hyperoxaluria (PH). Their core mission is to improve the quality of life and extend the life expectancy of patients suffering from this devastating ult...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Övrig verksamhet inom juridik, ekonomi, vetenskap och teknik
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556744267701
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrBioGaia Pharma AB
0 medarbejdereDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
ULTRAGENYX EUROPE GMBH
1–4 medarbejdereAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Calliditas Therapeutics AB
20–49 medarbejderePioneering novel treatments for rare renal and hepatic diseases globally.
Sixera Pharma AB
1–4 medarbejdereSmall biotech developing first treatment for rare Netherton syndrome.
AUTHERA AS
5 medarbejdereDeveloping novel FcRn-targeting biologics for therapeutic applications.
Udforsk mere
Spørgsmål om OxThera Intellectual Property AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo